Mass. Firm in Meningitis Case Eyes Bankruptcy Help
A Massachusetts pharmacy connected to a deadly meningitis outbreak has filed for bankruptcy protection.
The Chapter 11 filing Friday by the New England Compounding Center in U.S. Bankruptcy Court seeks to establish a fund to compensate those affected by the nationwide outbreak.
Contaminated injections from the company have been blamed for 39 deaths and 620 illnesses nationwide. The company says in the filing it hopes to achieve a quicker and fairer payout to creditors than it could through piecemeal litigation.
The Framingham-based company also announced it has appointed accountant Keith D. Lowey as independent director and chief restructuring officer.
Lowey says in a statement it's "difficult to comprehend the sense of loss so many people have experienced." He says the company recognizes the need to fairly compensate those affected.
(Copyright 2012 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.)
- Mass. Firm in Meningitis Case Eyes Bankruptcy Help
- Minn. Records 13th Illness from Tainted Steroids
- Senate Health Chair Wants New Drug Compound Rules
- Owner of Meningitis-Linked Pharmacy Takes Fifth
- Ham Lake Woman Sues After Contracting Meningitis
- Lawmakers Issue Subpoena for Pharmacy Director
- FDA Chief Will Testify at First Meningitis Hearing
- Tests Find Bacteria in Products of Mass. Pharmacy
- Meningitis Outbreak Toll: 377 Illnesses, 29 Deaths
- Mass. Firm Tied to Closed Pharmacy Issues Recall